Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directions

Lin, 2019, Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the global burden of disease study, J. Hematol. Oncol., 12, 96, 10.1186/s13045-019-0783-9 Toss, 2015, Molecular characterization and targeted therapeutic approaches in breast cancer, Breast Cancer Res., 17, 60, 10.1186/s13058-015-0560-9 Anderson, 2014, How many etiological subtypes of breast cancer: two, three, four, or more?, J. Natl. Cancer Inst., 106, 10.1093/jnci/dju165 Perou, 2000, Molecular portraits of human breast tumors, Nature., 406, 747, 10.1038/35021093 Kim, 2010, Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomy, Am. J. Clin. Oncol., 33, 23, 10.1097/COC.0b013e31819e2c02 Fogarty, 2010, Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer, Biochim. Biophys. Acta, 1804, 581, 10.1016/j.bbapap.2009.09.012 Hardie, 2007, AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy, Nat. Rev. Mol. Cell Biol., 8, 774, 10.1038/nrm2249 Hardie, 2011, AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function, Genes Dev., 25, 1895, 10.1101/gad.17420111 Garcia Dand Shaw, 2017, AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance, Mol. Cell, 66, 789, 10.1016/j.molcel.2017.05.032 Luo, 2010, AMPK as a metabolic tumor suppressor: control of metabolism and cell growth, Future Oncol., 6, 457, 10.2217/fon.09.174 Li, 2015, Targeting AMPK for cancer prevention and treatment, Oncotarget., 6, 7365, 10.18632/oncotarget.3629 Olivier, 2018, Promise and challenges for direct small molecule AMPK activators, Biochem. Pharmacol., 153, 147, 10.1016/j.bcp.2018.01.049 Jeon, 2016, Regulation and function of AMPK in physiology and diseases, Exp. Mol. Med., 48, 10.1038/emm.2016.81 Hawley, 2003, Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade, J. Biol., 2, 28, 10.1186/1475-4924-2-28 Hawley, 2005, Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase, Cell Metab., 2, 9, 10.1016/j.cmet.2005.05.009 Woods, 2005, Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells, Cell Metab., 2, 21, 10.1016/j.cmet.2005.06.005 Momcilovic, 2006, Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro, J. Biol. Chem., 281, 25336, 10.1074/jbc.M604399200 Gwinn, 2008, AMPK phosphorylation of raptor mediates a metabolic checkpoint, Mol. Cell, 30, 214, 10.1016/j.molcel.2008.03.003 He, 2014, AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity, Mol. Cell. Biol., 34, 148, 10.1128/MCB.00670-13 Hardie, 2013, AMPK: a target for drugs and natural products with effects on both diabetes and cancer, Diabetes., 2164, 10.2337/db13-0368 Kim, 2011, AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1, Nat. Cell Biol., 13, 132, 10.1038/ncb2152 Mack, 2012, AMPK-dependent phosphorylation of ULK1 regulates ATG9 localization, Autophagy., 8, 1197, 10.4161/auto.20586 Xu, 2012, Cross-talk between AMPK and mTOR in regulating energy balance, Crit. Rev. Food Sci. Nutr., 52, 373, 10.1080/10408398.2010.500245 Inoki, 2003, TSC2 mediates cellular energy response to control cell growth and survival, Cell., 115, 577, 10.1016/S0092-8674(03)00929-2 Jones, 2005, AMP-activated protein kinase induces a p53-dependent metabolic checkpoint, Mol. Cell, 18, 283, 10.1016/j.molcel.2005.03.027 Imamura, 2001, Cell cycle regulation via p53 phosphorylation by a 5’-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line, Biochem. Biophys. Res. Commun., 287, 562, 10.1006/bbrc.2001.5627 Wu, 2013, Shen et al. AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1, Mol. Cell, 49, 1167, 10.1016/j.molcel.2013.01.035 Doménech, 2015, AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest, Nat. Cell Biol., 17, 1304, 10.1038/ncb3231 Hardie, 2014, AMPK—sensing energy while talking to other signaling pathways, Cell Metab., 20, 939, 10.1016/j.cmet.2014.09.013 Bultot, 2012, AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase, Biochem. J., 443, 193, 10.1042/BJ20112026 Fullerton, 2013, Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin sensitizing effects of metformin, Nat. Med., 19, 1649, 10.1038/nm.3372 Merrill, 1997, AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle, Am. J. Phys., 273, E1107 Willows, 2017, Phosphorylation of AMPK by upstream kinases is required for activity in mammalian cells, Biochem. J., 474, 3059, 10.1042/BCJ20170458 Daval, 2005, Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes, J. Biol. Chem., 280, 25250, 10.1074/jbc.M414222200 Klionsky, 2008, Autophagy revisited: a conversation with Christian de Duve, Autophagy., 4, 740, 10.4161/auto.6398 Egan, 2011, Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy, Science., 331, 456, 10.1126/science.1196371 Dieudonne MN, Bussiere M, Dos S Antos E, Leneveu MC, Giudicelli Y, et al. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 2006; 345:271–279. Arditi, 2007, Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer, Horm. Metab. Res., 39, 9, 10.1055/s-2007-956518 Takahata, 2007, Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells, Cancer Lett., 250, 229, 10.1016/j.canlet.2006.10.006 Barb, 2006, Adiponectin: a link between obesity and cancer, Expert Opin. Investig. Drugs, 15, 917, 10.1517/13543784.15.8.917 Taliaferro-Smith, 2009, LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells, Oncogene., 28, 2621, 10.1038/onc.2009.129 Saxena, 2010, Metastasis suppression by adiponectin: LKB1 rises up to the challenge, Cell Adhes. Migr., 4, 358, 10.4161/cam.4.3.11541 Shrestha, 2016, Critical role of AMPK/FoxO3A Axis in globular adiponectin-induced cell cycle arrest and apoptosis in cancer cells, J. Cell. Physiol., 231, 357, 10.1002/jcp.25080 Mauro, 2018, Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer, FASEB J., 32, 52 Gelsomino, 2019, The emerging role of adiponectin in female malignancies, Int. J. Mol. Sci., 20, 2127, 10.3390/ijms20092127 Nekulova, 2016, ΔNp63α expression induces loss of cell adhesion in triple-negative breast cancer cells, BMC Cancer, 16, 782, 10.1186/s12885-016-2808-x Yi, 2020, Transcriptional suppression of AMPKα1 promotes breast cancer metastasis upon oncogene activation, Proc. Natl. Acad. Sci., 117, 8013, 10.1073/pnas.1914786117 Sanli, 2012, Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells, PLoS One, 7, 10.1371/journal.pone.0032035 Shaw, 2004, The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress, Proc. Natl. Acad. Sci. U. S. A., 101, 3329, 10.1073/pnas.0308061100 Hadad, 2009, Histological evaluation of AMPK signaling in primary breast cancer, BMC Cancer, 9, 307, 10.1186/1471-2407-9-307 Al-Maghrabi, 2017, AMPK expression patterns are significantly associated with poor prognosis in breast cancer patients, Ann. Diagn. Pathol., 29, 62, 10.1016/j.anndiagpath.2017.05.012 Fox, 2013, AMP-activated protein kinase α 2 isoform suppression in primary breast cancer alters AMPK growth control and apoptotic signaling, Genes Cancer., 4, 3, 10.1177/1947601913486346 Lee, 2009, AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin, Exp. Mol. Med., 41, 201, 10.3858/emm.2009.41.3.023 Jhaveri, 2015, AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer, Oncotarget., 6, 14754, 10.18632/oncotarget.4474 Zou, 2017, AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/ β- catenin signaling pathway activity, Mol. Med. Rep., 15, 899, 10.3892/mmr.2016.6094 Rattan, 2005, 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase, J. Biol. Chem., 280, 39582, 10.1074/jbc.M507443200 Lee, 2010, Regulation of mutual inhibitory activities between AMPK and Akt with quercetin in MCF-7 breast cancer cells, Oncol. Rep., 24, 1493 Zhang, 2012, Jun Lin, Guangyu Yao, Zelong Han, Bo Liang et al. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo, Breast Cancer Res. Treat., 136, 379, 10.1007/s10549-012-2270-7 Kim, 2013, Targeting the AMP-activated protein kinase for cancer prevention and therapy, Front. Oncol., 175 Shaw, 2005, The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin, Science., 310, 1642, 10.1126/science.1120781 Jiralerspong, 2009, Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer, J. Clin. Oncol., 27, 3297, 10.1200/JCO.2009.19.6410 Camacho, 2015, Metformin in breast cancer - an evolving mystery, Breast Cancer Res., 17, 88, 10.1186/s13058-015-0598-8 Hadad, 2011, Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial, Breast Cancer Res. Treat., 128, 783, 10.1007/s10549-011-1612-1 Hadad, 2014, Effects of metformin on breast cancer cell proliferation, the AMPK pathway, and the cell cycle, Clin. Transl. Oncol., 16, 746, 10.1007/s12094-013-1144-8 Zheng, 2012, 14-3-3σ regulation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast cancer cells via Akt inactivation, FEBS Lett., 586, 163, 10.1016/j.febslet.2011.11.034 Qu, 2014, Metformin reverses multidrug resistance and epithelial– mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells, Mol. Cell. Biochem., 386, 63, 10.1007/s11010-013-1845-x Rocha, 2011, Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth, Clin. Cancer Res., 17, 3993, 10.1158/1078-0432.CCR-10-2243 Pollak, 2010, Metformin and other biguanides in oncology: advancing the research agenda, Cancer Prev. Res. (Phila.), 3, 1060, 10.1158/1940-6207.CAPR-10-0175 Guo, 2017, Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathway, Oncotarget., 8, 60342, 10.18632/oncotarget.19466 Liu, 2015, Phenformin induces cell cycle change, apoptosis, and mesenchymal-epithelial transition and regulates the AMPK/mTOR/p70s6k and MAPK/ERK pathways in breast cancer cells, PLoS One, 10, 10.1371/journal.pone.0131207 Appleyard, 2012, Phenformin as prophylaxis and therapy in breast cancer xenografts, Br. J. Cancer, 106, 1117, 10.1038/bjc.2012.56 El-Masry, 2012, Effects of activation of AMPK on human breast cancer cell lines with different genetic backgrounds, Oncol. Lett., 3, 224, 10.3892/ol.2011.458 Gollavilli, 2015, AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation, FEBS J., 282, 3971, 10.1111/febs.13391 Fodor, 2016, Combined treatment of MCF-7 cells with AICAR and methotrexate, arrests cell cycle and reverses Warburg metabolism through AMP-activated protein kinase (AMPK) and FOXO1, PLoS One, 11, 10.1371/journal.pone.0150232 Zhong, 2016, Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner, Mol. Biol. Syst., 12, 1626 Lee, 2011, Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate- activated protein kinase (AMPK) activator, J. Biol. Chem., 286, 39247, 10.1074/jbc.M111.264598 Chou, 2014, AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt–MDM2–Foxo3a signaling axis, Cancer Res., 74, 4783, 10.1158/0008-5472.CAN-14-0135 Zafrakas, 2016, Sorafenib in breast cancer treatment: a systematic review and overview of clinical trials, World J. Clin. Oncol., 7, 331, 10.5306/wjco.v7.i4.331 Baselga, 2012, Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer, J. Clin. Oncol., 30, 1484, 10.1200/JCO.2011.36.7771 Fumarola, 2013, Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling, Breast Cancer Res. Treat., 141, 67, 10.1007/s10549-013-2668-x Deshmukh, 2015, Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells, Breast Cancer Res. Treat., 153, 79, 10.1007/s10549-015-3512-2 Hennekens, 1997, Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association, Circulation., 96, 2751, 10.1161/01.CIR.96.8.2751 Baron, 2003, A randomized trial of aspirin to prevent colorectal adenomas, N. Engl. J. Med., 348, 891, 10.1056/NEJMoa021735 Rothwell, 2012, Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomized controlled trials, Lancet., 379, 1591, 10.1016/S0140-6736(12)60209-8 Henry, 2017, Aspirin suppresses growth in PI3K-mutant breast cancer by activating AMPK and inhibiting mTORC1 signaling, Cancer Res., 77, 790, 10.1158/0008-5472.CAN-16-2400 Talarico, 2016, Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells, Sci. Rep., 6, 18673, 10.1038/srep18673 Kenlan, 2017, Fluorinated N,N’-diarylureas as novel therapeutic agents against cancer stem cells, Mol. Cancer Ther., 16, 831, 10.1158/1535-7163.MCT-15-0634 Johnson, 2019, Induction of AMPK activation by N, N’-Diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers, PLoS One, 14, 10.1371/journal.pone.0209392 Russo, 2007, Ins and outs of dietary phytochemicals in cancer chemoprevention, Biochem. Pharmacol., 74, 533, 10.1016/j.bcp.2007.02.014 Rivera, 2016, Anti-breast cancer potential of quercetin via the Akt/AMPK/mammalian target of rapamycin (mTOR) signaling cascade, PLoS One, 11, 10.1371/journal.pone.0157251 Yang, 2006, Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice, Cancer Res., 66, 4758, 10.1158/0008-5472.CAN-05-4529 Sethi, 2007, Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaBactivation, Blood., 109, 2727, 10.1182/blood-2006-10-050807 Jung, 2007, Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells, Exp. Mol. Med., 39, 715, 10.1038/emm.2007.78 Kim, 2013, Celastrol suppresses breast cancer MCF-7 cell viability via the AMP-activated protein kinase (AMPK)-induced p53-polo like kinase 2 (PLK-2) pathway, Cell. Signal., 25, 805, 10.1016/j.cellsig.2012.12.005 Qi, 2013, Baicalein reduces lipopolysaccharide-induced inflammation via suppressing JAK/STATs activation and ROS production, Inflamm. Res., 62, 845, 10.1007/s00011-013-0639-7 Kang, 2012, Baicalein inhibits oxidative stress-induced cellular damage via antioxidant effects, Toxicol. Ind. Health, 28, 412, 10.1177/0748233711413799 Aryal, 2014, Baicalein induces autophagic cell death through AMPK/ULK1 activation and down regulation of mTORC1 complex components in human cancer cells, FEBS J., 281, 4644, 10.1111/febs.12969 Jing, 2015, Effect of glycosylation patterns of Chinese eggplant anthocyanins and other derivatives on antioxidant effectiveness in human colon cell lines, Food Chem., 172, 183, 10.1016/j.foodchem.2014.08.100 Chen, 2015, Black rice anthocyanins suppress metastasis of breast cancer cells by targeting RAS/RAF/MAPK pathway, Biomed. Res. Int., 414250 Luo, 2014, Anti-metastasis activity of black rice anthocyanins against breast cancer: analyses using an ErbB2 positive breast cancer cell line and tumoral xenograft model, Asian Pac. J. Cancer Prev., 15, 6219, 10.7314/APJCP.2014.15.15.6219 Yang, 2016, Delphinidin-3-glucoside suppresses breast carcinogenesis by inactivating the Akt/HOTAIR signaling pathway, BMC Cancer, 16, 423, 10.1186/s12885-016-2465-0 Chen, 2018, Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells, BMC Cancer, 18, 342, 10.1186/s12885-018-4231-y Lü, 2010, Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update, Med. Sci. Monit., 16, RA93 Fried, 2009, Honokiol, a multifunctional antiangiogenic and antitumor agent, Antioxid. Redox Signal., 11, 1139, 10.1089/ars.2009.2440 Battle, 2005, The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells, Blood., 106, 690, 10.1182/blood-2004-11-4273 Shigemura, 2007, Honokiol, a natural plant product, inhibits the metastatic bone growth of human prostate cancer cells, Cancer., 109, 1279, 10.1002/cncr.22551 Deng, 2008, Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2), Liver Int., 28, 1458, 10.1111/j.1478-3231.2008.01767.x Li, 2008, Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells, Eur. J. Obstet. Gynecol. Reprod. Biol., 140, 95, 10.1016/j.ejogrb.2008.02.023 Garcia, 2008, Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells, Clin. Cancer Res., 14, 4267, 10.1158/1078-0432.CCR-08-0102 Nagalingam, 2012, Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis, Breast Cancer Res., 14, R35, 10.1186/bcr3128 Chen, 2012, Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells, Bioorg. Med. Chem., 20, 3031, 10.1016/j.bmc.2012.03.002 Kunnumakkara, 2017, Curcumin, the golden nutraceutical; multitargeting for multiple chronic diseases, Br. J. Pharmacol., 174, 1325, 10.1111/bph.13621 Ak, 2008, Antioxidant and radical scavenging properties of curcumin, Chem. Biol. Interact., 174, 27, 10.1016/j.cbi.2008.05.003 Gupta, 2013, Therapeutic roles of curcumin: lessons learned from clinical trials, AAPS J., 15, 195, 10.1208/s12248-012-9432-8 Guan, 2016, Curcumin suppresses proliferation and migration of MDA-MB- 231 breast cancer cells through autophagy-dependent Akt degradation, PLoS One, 11, 10.1371/journal.pone.0146553 Hashemzehi, 2018, Phytosomal-curcumin antagonizes cell growth and migration, induced by thrombin through AMP-kinase in breast cancer, J. Cell. Biochem., 119, 5996, 10.1002/jcb.26796 Shieh, 2013, Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells, J. Agric. Food Chem., 61, 6366, 10.1021/jf4012455 Constant, 1997, Alcohol, ischemic heart disease, and the French paradox, Clin. Cardiol., 20, 420, 10.1002/clc.4960200504 Tomé-Carneiro, 2013, Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence, Curr. Pharm. Des., 19, 6064, 10.2174/13816128113199990407 Gehm, 1997, Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor, Proc. Natl. Acad. Sci. U. S. A., 94, 14138, 10.1073/pnas.94.25.14138 Lin, 2010, Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation, J. Agric. Food Chem., 58, 1584, 10.1021/jf9035782 Jin, 2016, Pharmacological effects of berberine and its derivatives: a patent update, Expert Opin. Ther. Pat., 26, 229, 10.1517/13543776.2016.1118060 Chang, 2016, Berberine pretreatment confers cardioprotection against ischemia-reperfusion injury in a rat model of type 2 diabetes, Cardiovasc. Pharmacol. Ther., 21, 486, 10.1177/1074248415627873 Tan, 2015, Berberine interfered with breast cancer cells metabolism, balancing energy homeostasis, Anti Cancer Agents Med. Chem., 15, 66, 10.2174/1871520614666140910120518 Pan, 2017, Berberine enhances chemosensitivity and induces apoptosis through dose-orchestrated AMPK signaling in breast cancer, J. Cancer, 8, 1679, 10.7150/jca.19106 Sylvester, 2014, Potential role of tocotrienols in the treatment and prevention of breast cancer, Biofactors., 40, 49, 10.1002/biof.1116 Weng-Yew, 2009, Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesis, Nutr. Cancer, 61, 367, 10.1080/01635580802582736 Parajuli, 2015, Anticancer effects of c-Tocotrienol are associated with a suppression in aerobic glycolysis, Biol. Pharm. Bull., 38, 1352, 10.1248/bpb.b15-00306 Dronamraju, 2019, γ-Tocotrienol suppression of the Warburg effect is mediated by AMPK activation in human breast cancer cells, Nutr. Cancer, 71, 1214, 10.1080/01635581.2019.1599969